Grégory J. Wirth

Is it still worth pursuing the repurposing of metformin as a cancer therapeutic?

Targeted therapy for head and neck cancer: signaling pathways and clinical studies

Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism

Tissue microarrays of human tumor xenografts: characterization of proteins involved in migration and angiogenesis for applications in the development of targeted anticancer agents.